48 related articles for article (PubMed ID: 17245354)
1. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation.
Ma HI; Hueng DY; Shui HA; Han JM; Wang CH; Lai YH; Cheng SY; Xiao X; Chen MT; Yang YP
Int J Mol Sci; 2014 Mar; 15(3):4393-414. PubMed ID: 24625664
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression.
Chen SJ; Johnston J; Sandhu A; Bish LT; Hovhannisyan R; Jno-Charles O; Sweeney HL; Wilson JM
Hum Gene Ther Methods; 2013 Aug; 24(4):270-8. PubMed ID: 23895325
[TBL] [Abstract][Full Text] [Related]
3. Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver.
Jauze L; Vie M; Miagoux Q; Rossiaud L; Vidal P; Montalvo-Romeral V; Saliba H; Jarrige M; Polveche H; Nozi J; Le Brun PR; Bocchialini L; Francois A; Cosette J; Rouillon J; Collaud F; Bordier F; Bertil-Froidevaux E; Georger C; van Wittenberghe L; Miranda A; Daniele NF; Gross DA; Hoch L; Nissan X; Ronzitti G
JCI Insight; 2024 May; 9(11):. PubMed ID: 38753465
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.
Hadaczek P; Beyer J; Kells A; Narrow W; Bowers W; Federoff HJ; Forsayeth J; Bankiewicz KS
PLoS One; 2011; 6(11):e27728. PubMed ID: 22132130
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques.
Kistner A; Chichester JA; Wang L; Calcedo R; Greig JA; Cardwell LN; Wright MC; Couthouis J; Sethi S; McIntosh BE; McKeever K; Wadsworth S; Wilson JM; Kakkis E; Sullivan BA
Gene Ther; 2024 Mar; 31(3-4):128-143. PubMed ID: 37833563
[TBL] [Abstract][Full Text] [Related]
6. Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.
Hagen S; Baumann T; Wagner HJ; Morath V; Kaufmann B; Fischer A; Bergmann S; Schindler P; Arndt KM; Müller KM
Sci Rep; 2014 Jan; 4():3759. PubMed ID: 24457557
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic AAV gene delivery.
Li W
Blood; 2023 May; 141(19):2286-2288. PubMed ID: 37166928
[No Abstract] [Full Text] [Related]
8. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Zhan W; Muhuri M; Tai PWL; Gao G
Front Immunol; 2021; 12():673699. PubMed ID: 34046041
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization against HIV/AIDS by antibody gene transfer.
Yang L; Wang P
Viruses; 2014 Jan; 6(2):428-47. PubMed ID: 24473340
[TBL] [Abstract][Full Text] [Related]
10. Engineering the ABA plant stress pathway for regulation of induced proximity.
Liang FS; Ho WQ; Crabtree GR
Sci Signal; 2011 Mar; 4(164):rs2. PubMed ID: 21406691
[TBL] [Abstract][Full Text] [Related]
11. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
[TBL] [Abstract][Full Text] [Related]
12. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach.
Cao L; Lin EJ; Cahill MC; Wang C; Liu X; During MJ
Nat Med; 2009 Apr; 15(4):447-54. PubMed ID: 19270710
[TBL] [Abstract][Full Text] [Related]
13. AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.
Harding TC; Lalani AS; Roberts BN; Yendluri S; Luan B; Koprivnikar KE; Gonzalez-Edick M; Huan-Tu G; Musterer R; VanRoey MJ; Ozawa T; LeCouter RA; Deen D; Dickinson PJ; Jooss K
Mol Ther; 2006 May; 13(5):956-66. PubMed ID: 16580881
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
[TBL] [Abstract][Full Text] [Related]
15. Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.
Harding TC; Dickinson PJ; Roberts BN; Yendluri S; Gonzalez-Edick M; Lecouteur RA; Jooss KU
Hum Gene Ther; 2006 Aug; 17(8):807-20. PubMed ID: 16942441
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus (AAV) vectors in cancer gene therapy.
Santiago-Ortiz JL; Schaffer DV
J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
[TBL] [Abstract][Full Text] [Related]
17. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer.
Nguyen M; Huan-Tu G; Gonzalez-Edick M; Rivera VM; Clackson T; Jooss KU; Harding TC
Mol Ther; 2007 May; 15(5):912-20. PubMed ID: 17245354
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
